The Booming World of Assisted Reproductive Technology
The landscape of family building is rapidly evolving, and assisted reproductive technology (ART) is at the forefront of this transformation. Market analysts predict a meaningful surge in demand for these innovative treatments, driven by a confluence of factors.
A recent report from ResearchAndMarkets.com highlights the notable growth trajectory of the ART market. The market size is projected to jump from $34.35 billion in 2024 to $37.21 billion in 2025, representing a remarkable compound annual growth rate (CAGR) of 8.3%.
This surge in demand can be attributed to several key trends. Increasing maternal age, shifting societal norms surrounding family structure, the rise of medical tourism, and expanding healthcare infrastructure all contribute to the growing popularity of ART. Additionally, ongoing research and development in the field promise even more sophisticated and accessible treatments in the future.
The assisted reproductive technology (ART) market is on a rapid trajectory, with experts predicting its value to soar to $52.84 billion by 2029, growing at a remarkable compound annual growth rate (CAGR) of 9.2%. This surge is fueled by a confluence of factors, including the rise in maternal age, increasing demand for same-sex parenting, the expansion of medical tourism, the growth of healthcare infrastructure, and ongoing research and development in the field.
A major driver behind this growth is the escalating prevalence of infertility. The World Health Organization reported in April 2023 that approximately 17.5% of the global adult population, or roughly 1 in 6 adults, are affected by infertility, defined as the inability to conceive after a year of regular unprotected intercourse. This global concern is directly propelling the demand for ART, which encompasses a wide range of fertility treatments involving both male and female reproductive components.
Adding to this demand is the global obesity epidemic. The World Heart Federation estimated in March 2023 that 2.3 billion people worldwide, including children and adults, are affected by obesity or being overweight. This number is projected to rise to 2.7 billion by 2025, highlighting the significant impact obesity has on fertility and the subsequent need for specialized ART services.
The ART market is also witnessing a technological revolution, with companies actively developing cutting-edge solutions to gain a competitive edge. in October 2022, Alife Health introduced the Alife Assist platform, a suite of data-driven, AI-powered products designed to revolutionize the IVF process. Comprising Stim assist, Embryo Assist, and Insights, this platform caters to reproductive endocrinologists, embryologists, and clinic administrators, empowering them with tools for improved clinical decision-making, streamlined clinic operations, optimized medication dosing, precise embryo grading, and real-time performance monitoring. The integration of this technology elevates the patient experience while concurrently enhancing IVF success rates.
Building on this trend, Thermo Fisher Scientific Inc., a renowned US-based biotechnology firm, unveiled two groundbreaking, next-generation sequencing-based options in July 2023. These products, specifically crafted to support preimplantation genetic testing-aneuploidy (PGT-A) in IVF and intracytoplasmic sperm injection (ICSI) research, are designed for use in reproductive health labs. The Ion ReproSeq PGT-A Kit and the Ion ampliseq Polyploidy Kit are the first research-use assays of their kind, compatible with the Ion Torrent Genexus Integrated Sequencer. this extensive workflow, spanning from initial sample processing to final results analysis, simplifies PGT-A testing, which identifies chromosomal irregularities in embryo samples, offering invaluable genetic insights to possibly enhance future pregnancy success rates and improve the well-being of future generations. The integrated sequencer streamlines the research process, enabling simultaneous templating, sequencing, and analysis. Moreover, the Ion AmpliSeq polyploidy Panel kit features quality control measures to detect contamination, prevent sample mix-ups, and identify triploidy in embryos.
In a move consolidating its position in the ART market, CooperCompanies, a US-based medical device firm, acquired Cook Medical’s Reproductive Health business in November 2023 for $300 million. This strategic acquisition expands CooperSurgical’s portfolio of medical devices and strengthens its standing as a global leader in fertility and women’s health. Cook Medical, a US-based supplier of ART products, provides crucial additional resources to CooperCompanies’ existing offerings.
The Future is Shining: Market Value Poised to Expand Significantly
The global market is experiencing a surge in growth, with projections indicating impressive expansion in the coming years. A recent report reveals a promising outlook, predicting a ample increase in market value by 2029.
The report, comprising 200 pages, delves into the intricate details of this burgeoning market, offering valuable insights into its current state and future trajectory. The focus of the analysis spans from 2025 to 2029, providing a comprehensive overview of the market’s anticipated performance during this period.
By 2025, the estimated market value is projected to reach a staggering $37.21 billion. This figure is expected to climb even further, reaching $52.84 billion by 2029. This remarkable growth trajectory translates into a compound annual growth rate (CAGR) of 9.2%, underscoring the market’s robust potential for expansion.
This significant growth presents a wealth of opportunities for businesses operating within this sector.
Navigating the Global Landscape of Assisted reproductive Technology
Assisted Reproductive Technology (ART) has revolutionized the landscape of fertility, offering hope and solutions to individuals and couples struggling to conceive. The global market, driven by increasing demand, technological advancements, and evolving societal perspectives, is witnessing significant growth. Leading companies are at the forefront of this transformation, constantly pushing boundaries to improve treatments, expand accessibility, and enhance patient outcomes. Let’s explore some of the major players shaping the future of fertility:
These industry giants contribute to various facets of ART, including: developing innovative diagnostic tools, manufacturing advanced equipment, providing specialized laboratory solutions, and offering comprehensive fertility treatments. Their dedication to research, clinical excellence, and patient-centric approaches positions them as pivotal forces in this rapidly evolving field.
Here’s a closer look at some key companies leading the charge:
-
Cooper Surgical Inc. plays a crucial role in providing advanced surgical solutions, equipment, and technologies for various reproductive healthcare procedures.
-
Ferring Pharmaceuticals Ltd. focuses on developing and manufacturing innovative medications, especially those targeting fertility challenges.
-
Hamilton Thorne Ltd. is recognized for its cutting-edge instrumentation and equipment essential for reproductive laboratory procedures.Their contributions encompass tools for sperm analysis, embryo handling, and advanced imaging.
-
merck KGaA , a global science and technology leader, is actively involved in developing and delivering innovative fertility treatments, diagnostic solutions, and related pharmaceuticals.
-
Genea Limited stands as a prominent player in the global fertility sector, specializing in fertility preservation, sperm banking, and genetic testing. Their focus extends to providing comprehensive solutions across the spectrum of reproductive healthcare needs.
-
California Cryobank and European Sperm Bank play vital roles in providing ethical and reliable sperm donation services, supporting individuals and couples seeking fertility assistance.
-
OvaScience Inc. , specializing in innovative fertility solutions, focuses on developing advanced technologies aimed at enhancing egg quality and improving treatment outcomes.
-
Bloom IVF Center , known for its expertise in assisted reproductive technologies, provides comprehensive fertility services, including IVF, egg freezing, and genetic screening.
-
Vitrolife AB plays a critical role in supplying essential consumables and equipment used in IVF laboratories worldwide. Their contributions encompass reagents, media, incubators, and other critical tools.
-
FUJIFILM irvine Scientific Inc. a leading provider of media, reagents, and diagnostic solutions for assisted reproductive technologies. Their comprehensive offerings cater to diverse needs within fertility clinics worldwide.
-
Nidacon International AB focuses on developing advanced technologies for embryo culture and manipulation, playing a vital role in improving IVF outcomes.
-
Monash IVF Group Ltd. , renowned for its expertise in IVF, offers a comprehensive range of fertility treatments, encompassing IVF, egg donation, sperm donation, and genetic testing.
-
Cook Medical , specializing in medical devices, provides innovative solutions for reproductive healthcare, including devices for assisted insemination, egg retrieval, and embryo transfer.
-
INVO Bioscience Inc. is revolutionizing fertility treatment with its unique approach, developing and commercializing products designed for personalized, outpatient, and convenient treatment options.
These companies represent a dynamic segment of the healthcare industry, committed to improving fertility outcomes, empowering individuals, and shaping the future of reproductive healthcare. Their collective efforts underscore the transformative impact ART has on countless lives worldwide.
Key Players Shaping the Future of fertility
The fertility landscape is evolving rapidly, driven by advancements in technology, scientific research, and a growing awareness of reproductive health.At the forefront of this evolution are a diverse group of companies and organizations dedicated to helping individuals and couples achieve their family planning goals.
These pioneers are not only developing innovative treatments and technologies but are also actively shaping the conversation around fertility, breaking down stigmas, and ensuring access to care for all.
Let’s explore some of the key players making a significant impact in this vital field:
Thermo Fisher Scientific Inc.: A global leader in scientific research and laboratory technology, Thermo Fisher plays a crucial role in providing the tools and resources essential for fertility research and treatment. Their offerings range from advanced diagnostic equipment to reagents and consumables used in IVF and genetic testing. Boston Scientific Corporation: A renowned medical device company, Boston Scientific has a dedicated division focused on women’s health, including fertility. Their innovative products, such as minimally invasive surgical devices and fertility tracking technologies, are helping to improve the effectiveness and safety of fertility treatments. Anecova Sa: This European company specializes in developing and commercializing advanced fertility solutions. Their expertise in developing next-generation diagnostic tools and personalized treatment approaches is paving the way for more precise and effective fertility care.
Carolinas Fertility Institute: A leading fertility clinic in the United States, Carolinas Fertility institute is renowned for its comprehensive reproductive services, including IVF, egg freezing, and genetic testing. They are committed to providing personalized care and support to patients throughout their fertility journey.
Microm ltd.: this company focuses on developing cutting-edge technologies for assisted reproductive technology (ART). Their flagship product is the TEMA system, a platform that automates and optimizes several steps in the IVF process, resulting in improved efficiency and success rates.
Inception Sciences Inc.: A company dedicated to improving the lives of infertile couples, Inception Sciences specializes in developing novel therapeutics for male factor infertility. Their research and development efforts are focused on addressing the underlying causes of male infertility, offering hope to those who have struggled to conceive.
Progyny Inc.: Progyny is a healthcare company focused on providing comprehensive fertility benefits to employers and their employees. They are committed to making fertility care more accessible and affordable by offering innovative insurance plans and support programs.
Oxford Gene Technology IP Ltd.: This company plays a vital role in genetic testing for reproductive health. They develop and provide advanced genetic analysis tools that help identify potential genetic risks and guide personalized treatment decisions.
IVI-RMA Global: A leading global network of fertility clinics, IVI-RMA offers a wide range of fertility treatments, including IVF, egg donation, and surrogacy. With locations worldwide, they provide access to cutting-edge fertility care for a global patient population.
Boston IVF: This renowned clinic, with locations across the United States, is committed to delivering compassionate and personalized fertility care. They offer a full spectrum of reproductive services,from basic fertility testing to advanced IVF procedures.
CARE Fertility Group: This UK-based fertility group operates multiple clinics throughout the country, providing comprehensive fertility services and support. They are known for their expertise in fertility preservation and egg freezing.
Virtus Health: One of Australia’s largest fertility providers, Virtus Health offers a wide range of fertility treatments, including IVF, egg donation, and surrogacy. Their focus on patient care and evidence-based practices has made them a trusted name in the field.
Reproductive Medicine Associates of New York: As one of the oldest and largest fertility centers in the United States, RMA of New York is known for its pioneering work in fertility research and treatment. They have a long history of helping patients achieve their dream of having a family.
Shady Grove Fertility: With numerous clinics across the East Coast of the United States, Shady Grove Fertility is renowned for its patient-centric approach and comprehensive fertility services. They offer a wide range of options to meet individual patient needs.
CCRM Fertility: CCRM Fertility is a leading fertility centre with locations across North america, offering a comprehensive range of fertility treatments and services.
New hope Fertility Center: Located in the heart of California, New Hope Fertility center provides personalized care and innovative treatment options to individuals and couples struggling with infertility.
Houston Fertility Institute: A renowned fertility clinic in Texas, Houston Fertility Institute offers a comprehensive range of fertility services, including IVF, egg freezing, and genetic testing. Their team of highly experienced specialists is dedicated to providing personalized and compassionate care.
Pacific Fertility Center: With a long-standing reputation for excellence, Pacific Fertility Center is a leading fertility clinic in the San Francisco Bay Area, offering a full spectrum of fertility treatments and support services. RMA of New Jersey: As part of the larger Reproductive Medicine Associates network, RMA of New Jersey provides comprehensive fertility services to patients across the state. Their team of specialists is committed to delivering personalized care and helping patients achieve their family planning goals.
Sher Fertility Institute: With locations in California and Nevada, Sher Fertility Institute is dedicated to providing compassionate and personalized fertility care. They offer a full range of treatments, from basic fertility testing to advanced IVF procedures.
these are just a few of the many companies and organizations shaping the future of fertility. Through innovation, research, and a commitment to patient well-being, they are making a profound impact on the lives of millions of people around the world.
The assisted reproductive technology market is experiencing significant growth, driven by increasing infertility rates, rising disposable incomes, and advancements in medical technology. A comprehensive market report by ResearchAndMarkets.com sheds light on key players shaping this landscape.
- IVF Florida
- ORM Fertility
- HRC Fertility
- Arizona Center for Reproductive Endocrinology & Infertility
- San Diego Fertility Center
- Fertility Centers of Illinois
ResearchAndMarkets.com, a renowned source for international market research, offers a wealth of details on global and regional markets, key industries, leading companies, new products, and the latest trends.
For more in-depth insights into this evolving market, visit:
https://www.researchandmarkets.com/r/icwq3x
What are the different categories of key players in the fertility landscape and who are some notable examples within each category?
Here’s a summarized and formatted list of the key players in the fertility landscape,categorized based on their roles and contributions:
Sperm and Egg Donation Services
- California Cryobank
- European Sperm Bank
Fertility Technology and Innovation
- OvaScience Inc.
- Nidacon international AB
- Inception Sciences Inc. (male factor infertility)
- Microm Ltd. (ART technologies)
Fertility Clinics and Treatment Providers
- Bloom IVF Center (USA)
- monash IVF Group Ltd. (Australia)
- Carolinas fertility Institute (USA)
- IVI-RMA Global (global network)
- Boston IVF (USA)
- CARE Fertility Group (UK)
- Virtus Health (Australia)
- reproductive Medicine Associates of New York (USA)
- Shady Grove Fertility (USA)
Fertility Supplements and Consumables
- Vitrolife AB
- FUJIFILM Irvine Scientific Inc.
- Cook Medical
Personalized and Outpatient Fertility Treatment
- INVO Bioscience inc.
Access to Fertility Care and Benefits
- Progyny Inc. (fertility benefits for employers)
Genetic Testing and Analysis
- Oxford gene Technology IP Ltd.
Scientific Research and laboratory Technology
- Thermo Fisher Scientific Inc.
- Boston Scientific Corporation (women’s health division)
Advanced Fertility Solutions
- Anecova SA (Europe)
These key players, with their diverse expertise and innovative offerings, play notable roles in shaping the future of fertility.Their collective efforts contribute to improving fertility outcomes, enhancing access to care, and driving advancements in reproductive health.
